# Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection

> **NCT01406587** · PHASE2 · COMPLETED · sponsor: **Pinnacle Pharmaceuticals, Inc.** · enrollment: 261 (actual)

## Conditions studied

- Urinary Tract Infection

## Interventions

- **DRUG:** PP4001
- **DRUG:** PP4001
- **DRUG:** PP4001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01406587
- **Lead sponsor:** Pinnacle Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2011-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406587, "Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01406587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*